MeSH tree: D02.455.426.559.847.562
Scientists in the Blavatnik Institute at Harvard Medical School and MIT have created a new family of tools that, for the first time, illuminates the missing half of how the immune system uses molecules called cytokines to ...
Feb 11, 2026
0
17
Patients with early-stage Hodgkin lymphoma had impressive response rates when treated with a novel combination of therapies—brentuximab vedotin and nivolumab combined with chemotherapy drugs doxorubicin and dacarbazine—according ...
Jan 25, 2026
0
12
Anthracyclines are among the most widely used chemotherapy drugs and have been a mainstay of cancer treatment for more than 30 years. Their extraordinary efficacy against numerous solid and hematologic tumors means that they ...
Jan 15, 2026
0
18
Leah Kovitch was pulling invasive plants in the meadow near her home one weekend in late April when a tick latched onto her leg.
Dec 1, 2025
0
16
Researchers at Dartmouth Hitchcock Medical Center have developed a way to diagnose Lyme disease earlier and more accurately than traditional testing methods.
Nov 14, 2025
0
16
A naturally-occurring protein that tends to be expressed at higher levels in breast cancer cells boosts the effectiveness of some anticancer agents, including doxorubicin, one of the most widely used chemotherapies, and a ...
Nov 12, 2025
0
34
Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have demonstrated that doxycycline, a commonly available and inexpensive antibiotic, can improve survival rates and neurological ...
Nov 12, 2025
0
14
You may not give much thought to your armpits, apart from checking whether they need another swipe of deodorant. But this small, often overlooked patch of skin is one of the body's busiest crossroads. Beneath those folds ...
Nov 6, 2025
0
12
A commonly prescribed antibiotic could help reduce the risk of some young people developing schizophrenia, new research published in the American Journal of Psychiatry suggests.
Nov 5, 2025
0
37
A research team has developed a new chemotherapeutic agent, LiPyDau, which shows remarkable efficacy against multiple tumor types in preclinical studies. Published in the journal Molecular Cancer, the study introduces a highly ...
Oct 30, 2025
0
54
